🔗 Permalink

Inventor profile of:

Amnon HOffman

City:

Jerusalem

Country:

Israel

Published Applications:

Last publication date:

2024-10-10

Top Assignees for applications by Amnon HOffman

The entities that hold a legal rights for patent applications filed by inventor HOffman Amnon:

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. 11 Jerusalem, Israel
THE REGENTS OF THE UNIVERSITY OF MICHIGAN 3 Ann Arbor, MI United States
TECHNISCHE UNIVERSITAET MUENCHEN 1 Munich, Germany
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. 1 Jersusalem, Israel

Recent patent applications by HOffman Amnon

Amnon HOffman from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-10

US20240335391A1

Human necessities

FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS

#2 | 2023-12-14

US20230398080A1

Human necessities

FLOATING DRUG DELIVERY SYSTEMS COMPRISING CANNABINOIDS

#3 | 2023-10-19

US20230331781A1

Chemistry; metallurgy

PAR4 DERIVED PEPTIDES, ANALOGS AND USES THEREOF

#4 | 2023-09-07

US20230277449A1

Human necessities

ORAL CAVITY POLYMERIC DELIVERY SYSTEMS

#5 | 2022-04-21

US20220119474A1

Chemistry; metallurgy

PAR4 DERIVED PEPTIDES, ANALOGS AND USES THEREOF

#6 | 2022-01-20

US20220016218A1

Human necessities

LIPOPHILIC PEPTIDE PRODRUGS

#7 | 2021-10-14

US20210315803A1

Human necessities

SUSTAINED-RELEASE INJECTABLE ANTIBIOTICAL FORMULATION

#8 | 2020-10-15

US20200323962A1

Human necessities

LIPOPHILIC PEPTIDE PRODRUGS

#9 | 2020-09-10

US20200283483A1

Chemistry; metallurgy

N-methylated cyclic peptides and their prodrugs

#10 | 2020-08-20

US20200262871A1

Chemistry; metallurgy

Somatostatin prodrugs

#11 | 2020-01-09

US20200009067A1

Human necessities

Formulation and method for increasing oral bioavailability of drugs

#12 | 2019-06-20

US20190185516A1

Chemistry; metallurgy

Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (MyD88)

#13 | 2018-11-15

US20180325861A1

Human necessities

NOVEL CANNABINOID FORMULATIONS

#14 | 2016-01-07

US20160002295A1

Chemistry; metallurgy

Methods and compositions for the treatment of bone remodeling disorders

#15 | 2014-11-27

US20140348926A1

Human necessities

FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS

#16 | 2014-07-31

US20140212444A1

Human necessities

Compositions and methods for inducing an immune response

#17 | 2014-01-16

US20140018323A1

Human necessities

Sustained-release injectable formulation

#18 | 2013-02-14

US20130040982A1

Human necessities

ORAL SUSTAINED RELEASE FORMULATION OF HUPERZINE A

#19 | 2012-10-25

US20120270774A1

Chemistry; metallurgy

MACROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS FOR PREVENTING OR TREATING HIV INFECTION

#20 | 2012-06-07

US20120141516A1

Human necessities

Compositions and methods for inducing an immune response

#21 | 2012-02-09

US20120035140A1

Human necessities

Carbamoylphosphonates as inhibitors and uses thereof

#22 | 2008-10-02

US20080242600A1

Chemistry; metallurgy

Backbone Cyclized Melanocortin Stimulating Hormone (Alpha Msh) Analogs

#23 | 2008-08-28

US20080206145A1

Human necessities

Gastro-Retentive Diagnostic Assemblies

InventorID:

91830 ⎘